On Demand Webinar
Unlocking innovation: What Pharma deals reveal about tomorrow’s therapies
All new technologies making a big impact. But what’s next? Our experts have been interrogating our dealmaking data to find out. In this webinar we’ll take a therapy area agnostic look into upcoming mechanisms and technologies which just might be the next ADC or GLP-1.
On Demand Webinar
Cliffhanger: Portfolio Tactics to Scale the $300bn Patent Cliff
This webinar will unpack the scale of the impending patent cliff, spotlight the top 10 drugs facing expiry, and reveal how large pharma’s growth gap is driving new portfolio strategies.
Report / eBook
Pharma v Biotech:
New Rules?
How are pricing pressures, policy shifts, and the rise of consumer influence reshaping the pharmaceutical sector? Find out in our Pharma v Biotech: New Rules? report.
Evaluate radically transforms your confidence in strategic portfolio decisions.
In biopharma, making the right decisions has an incredible impact on patients’ lives.
Making those decisions requires a deep understanding of your market; from identifying opportunities and mitigating risk to evaluating assets and pipelines.
Evaluate provides a complete and dynamic view of the pharmaceutical market, with innovative solutions that bring together technology, real-world data, and deep expertise to help you make portfolio decisions that drive growth.
In biopharma, making the right decisions has an incredible impact on patients’ lives.
Making those decisions requires a deep understanding of your market; from identifying opportunities and mitigating risk to evaluating assets and pipelines.
Evaluate provides a complete and dynamic view of the pharmaceutical market, with innovative solutions that bring together technology, real-world data, and deep expertise to help you make portfolio decisions that drive growth.
HOW WE HELP
Connected data gives you a clearer picture.
Evaluate gives you the understanding and time you need to drive better decisions.
Market Opportunity Sizing
Identify the market that offers the greatest potential for your business so you can confidently prioritise assets and allocate resources.
Commercial Opportunity Assessment
Develop a robust view of potential partners and licensing opportunities to boost your pipeline and amplify your commercial success.
Competitive Landscape Analysis
Build a clear analysis of the evolving landscape – market dynamics, emerging trends and key players – and make strategic moves that strengthen your position.
Company Profiling
Monitor key companies so you can track potential partners and competitors and find opportunities in a constantly changing environment.
Asset Screening
Obtain a clear and unbiased assessment of asset value to drive licensing decisions and ensure you invest in assets with the highest potential for success.
Deal Benchmarking
Bring confidence to your allocation strategy with timely external benchmarking data across the R&D landscape.
We collect,
collaborate and connect.
OUR SOLUTIONS
Insight at Your Fingertips
Access our world-class forecasting, analysis and machine learning-driven insight to help you reduce risk, maximise returns, and make smarter decisions about your portfolio strategy.
MARKET REPORTS
Trends & Analysis
Dive into our market reports covering sector performance and valuation, emerging trends and global forecasts. Stay ahead of the competition with the latest developments that impact your portfolio strategy.
OUR SERVICES
Consulting & Analytics
Tap into our expertise and reach your goals with our collaborative team of specialists, providing technology-enabled consulting, strategic commercial insights, and recommendations across the product lifecycle.
Latest Solutions & Insights
Understand the context. Data-driven insights and analysis for the pharma, biotech and medtech sectors.
Report/eBook
20 Mar 2026
2025 Review: Capital’s Better
Biopharma capital returned in 2025. But not for everyone. After a significant dry spell, capital began to flow…
Blog
20 Mar 2026
Three Things we Learned in our 2026 Orphan Drugs Webinar
Orphan drugs are forecast to make up 21% of all prescription drug sales by 2032, according to Evaluate…
Infographic
17 Mar 2026
2026 Orphan Drugs Infographic:
Orphan drug developers are navigating a more complex landscape. FDA decision making has proved unpredictable, and rare disease…
Webinar
12 Mar 2026
Unlock Strategic Insights for Pharma: Custom Competitive Intelligence and Landscape Monitoring
Establish a consistent baseline: build an aligned, comprehensive view of competitor intelligence. Monitor in real-time: stay updated on…
Press Release
12 Mar 2026
Evaluate Releases 2026 Orphan Drug Report
Report reveals that FDA temperament and blockbuster drugs fall short of disrupting the ever-increasing orphan drug market LONDON…
Blog
12 Mar 2026
Orphan Drugs at a Crossroads: Bigger Numbers, Tougher Calls
Drugs for rare diseases have played an increasingly significant role in the biopharma market for years. I’ve been…
Report/eBook
11 Mar 2026
Orphan Drugs Outlook 2032: Sales, Pipeline & Policy for Rare Diseases
Orphan drugs are still growing. But the environment they operate in is changing fast. Rare disease therapies are…
Case Study
11 Mar 2026
Long-term Competitive Landscape Monitoring: How Evaluate Helped a Leading Pharmaceutical Company Transform Its Competitive Intelligence Function
A top 20 pharmaceutical company was overwhelmed by the daily volume of competitive activity and needed a way…
Webinar
17 Feb 2026
Orphan Drugs: A safe(r) passage amid stormy waters?
How orphan drug sales and pipelines are evolving amid uncertainty Which companies and franchises are driving rare disease…
Report/eBook
27 Jan 2026
#JPM2026 Post-Event Report
Report/eBook
23 Jan 2026
Navigating China’s Rise: Strategic Playbook for Global Pharma
How to unlock opportunity, manage risk, and make smarter decisions as the axis of the world’s pharma innovation…
Blog
23 Jan 2026
Three Things we Learned in our 2026 Preview Webinar
Obesity. China. FDA turmoil. Our pharma 2026 Preview webinar was not the place to look for a change…
Report/eBook
21 Jan 2026
Pharma Forecasting Trends for 2026: What’s Shaping the Year Ahead
As forecasting teams head into 2026, expectations continue to rise. This year’s report captures the key trends shaping…
Infographic
20 Jan 2026
2026 Biopharma Outlook Infographic
Biotech is back! But it’s not quite as simple as that. After years of volatility, the sector heads…
Report/eBook
19 Jan 2026
Achieving Excellence in Long Range Pharmaceutical Forecasting
Understanding the challenges of the long-range planning (LRP) cycle is only the first step. The real question is…
